Scarica l'app Stockscreener
44.23
0.07%
0.03
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$44.20
Aprire:
$44.4
Volume 24 ore:
29.91M
Relative Volume:
1.50
Capitalizzazione di mercato:
$65.74B
Reddito:
$20.62B
Utile/perdita netta:
$3.56B
Rapporto P/E:
18.55
EPS:
2.3847
Flusso di cassa netto:
$3.48B
1 W Prestazione:
-2.34%
1M Prestazione:
-23.27%
6M Prestazione:
-53.96%
1 anno Prestazione:
-57.71%
Intervallo 1D:
$44.02
$45.22
Intervallo di 1 settimana:
$43.89
$45.83
Portata 52W:
$43.89
$109.50
Boston Scientific Corp Stock (BSX) Company Profile
Nome
Boston Scientific Corp
Settore
Industria
Telefono
508-683-4000
Indirizzo
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Compare BSX vs ABT, SYK, MDT, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
44.23 | 65.70B | 20.62B | 3.56B | 3.48B | 2.3847 |
ABT
Abbott Laboratories
|
94.12 | 162.41B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
332.71 | 121.18B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
80.98 | 103.07B | 36.36B | 4.84B | 5.43B | 3.7212 |
EW
Edwards Lifesciences Corp
|
90.78 | 51.66B | 6.30B | 1.07B | 1.09B | 1.8406 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-30 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2025-10-03 | Downgrade | Erste Group | Buy → Hold |
| 2025-09-08 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2025-06-16 | Iniziato | Leerink Partners | Outperform |
| 2025-04-16 | Aggiornamento | Needham | Hold → Buy |
| 2025-01-10 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-10-18 | Downgrade | Needham | Buy → Hold |
| 2024-05-30 | Iniziato | Goldman | Buy |
| 2024-02-01 | Aggiornamento | Mizuho | Neutral → Buy |
| 2023-07-19 | Iniziato | Robert W. Baird | Outperform |
| 2023-06-30 | Iniziato | CL King | Buy |
| 2023-05-30 | Ripresa | Morgan Stanley | Overweight |
| 2023-03-29 | Iniziato | UBS | Buy |
| 2022-12-22 | Iniziato | Mizuho | Neutral |
| 2022-12-20 | Ripresa | Citigroup | Buy |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-07-06 | Iniziato | Wolfe Research | Outperform |
| 2022-05-27 | Aggiornamento | Needham | Hold → Buy |
| 2022-04-13 | Ripresa | Truist | Buy |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-05-26 | Downgrade | Needham | Buy → Hold |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-15 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-17 | Iniziato | Truist | Buy |
| 2020-09-11 | Iniziato | Wolfe Research | Peer Perform |
| 2020-04-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | Aggiornamento | Goldman | Neutral → Buy |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Neutral |
| 2020-02-06 | Ripresa | BTIG Research | Buy |
| 2019-12-30 | Reiterato | Cowen | Outperform |
| 2019-12-19 | Downgrade | Needham | Strong Buy → Buy |
| 2019-09-05 | Ripresa | JP Morgan | Overweight |
| 2019-09-03 | Ripresa | Barclays | Overweight |
| 2019-05-13 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2018-11-28 | Iniziato | UBS | Buy |
| 2018-10-16 | Iniziato | Barclays | Overweight |
| 2018-10-02 | Reiterato | Morgan Stanley | Overweight |
| 2018-09-07 | Reiterato | Needham | Strong Buy |
| 2018-09-04 | Aggiornamento | Jefferies | Hold → Buy |
| 2018-07-06 | Reiterato | Needham | Strong Buy |
| 2018-06-27 | Iniziato | Bernstein | Outperform |
| 2018-04-26 | Reiterato | Needham | Strong Buy |
Mostra tutto
Boston Scientific Corp Borsa (BSX) Ultime notizie
Brain Implants Market Size to Reach USD 18.39 Billion by 2035, Growing at 9.99% CAGR | SNS Insider - GlobeNewswire Inc.
symbol__ Stock Quote Price and Forecast - CNN
Boston Scientific (NYSE:BSX) Gains Fresh Market Attention - Kalkine Media
TD Cowen Maintains a Buy Rating on Boston Scientific (BSX) - Insider Monkey
Stifel Adjusts Price Target on Boston Scientific to $65 From $75, Maintains Buy Rating - marketscreener.com
BSX Maintains Buy Rating by Jefferies -- Price Target Lowered to $67.00 - GuruFocus
BSX Stock | Boston Scientific Corp Q1 2025 Earnings Call Bear Attack (FjRIiYMEgO) - Mshale
Boston Scientific (BSX) Faces 52.54% Decline Amid Weak Momentum Grades - GuruFocus
Jefferies Adjusts Price Target on Boston Scientific to $67 From $100, Maintains Buy Rating - marketscreener.com
Boston Scientific Corp (BSX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Boston Scientific (BSX) Gains As Market Dips: What You Should Know - Yahoo Finance
Boston Scientific Corp. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Piper Sandler Maintains Overweight Rating for Boston Scientific (BSX) - Insider Monkey
Jim Cramer on Boston Scientific: “This Whole Cohort Is Just Too Hard to Own” - Insider Monkey
Here’s How Much You Would Have Made Owning Boston Scientific Stock In The Last 15 Years - Benzinga
Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic? - Yahoo Finance UK
Boston Scientific stock hits 52-week low at 44.41 USD By Investing.com - Investing.com Australia
Boston Scientific Spinal Cord Stimulator Lawsuit for SCS Injuries - robertkinglawfirm.com
Boston Scientific stock hits 52-week low at 44.41 USD - Investing.com UK
Truist Cuts Boston Scientific (BSX) ’s Target as Doctors Change How They Use Its Heart Device - Insider Monkey
Boston Scientific Corp Recalls Orca Sterile Single-Use Air/Water and Suction Valves - marketscreener.com
Boston Sci-Mirus pact lifts med-tech dealmaking to record $4.5B in May - BioWorld News
Boston Scientific Corp (BSX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Boston Scientific Corp (BSX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Trueblood Wealth Management, LLC's Boston Scientific Corp(BSX) Holding History - GuruFocus
Boston Scientific Corp (BSX) Stock Down 4.2% -- Now Undervalued? GF Score: 75/100 - GuruFocus
Boston Scientific (BSX) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance
Boston Scientific Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
CAFC Affirms Denial of Preliminary Injunction for Boston Scientific in Spinal Ablation Patent Dispute Against Stryker - IPWatchdog.com
Stryker Fends Off Boston Scientific Bid to Block Ablation Device - Bloomberg Law News
Below Expected Outlook Pressured Boston Scientific (BSX) in Q1 - Yahoo Finance
Boston Scientific Corp. Stock (US10117L1017): Short interest jumps while analysts stay positive - AD HOC NEWS
Why Did ADBE, CHWY, BSX Slump To 52-Week Lows Last Week? - TradingView
Truist Reiterates Buy Rating for Boston Scientific (BSX) - Insider Monkey
Boston Scientific Eyes Neurovascular Growth With Penumbra Thunderbolt Clearance - Yahoo Finance
Boston Scientific Stock Price Decline Analysis - Intellectia AI
Boston Scientific shares plunge 53% amid lowered growth forecasts and product challenges - Pluang
UniSuper Management Pty Ltd Has $72.53 Million Stake in Boston Scientific Corporation $BSX - MarketBeat
Penumbra’s FDA nod for clot removal tech a win for Boston Scientific - Yahoo Finance
Polen Capital Management LLC Sells 1,578,734 Shares of Boston Scientific Corporation $BSX - MarketBeat
Meiji Yasuda America Inc Makes New Investment in Boston Scientific Corporation $BSX - MarketBeat
Nuveen LLC Lowers Stock Holdings in Boston Scientific Corporation $BSX - MarketBeat
Great Lakes Advisors LLC Has $169.42 Million Stake in Boston Scientific Corporation $BSX - MarketBeat
Analyst recommendations: Adobe, Boston Scientific, Casey's General Stores, Kla Corporation, Zillow Group… - marketscreener.com
Aviva PLC Has $141.66 Million Holdings in Boston Scientific Corporation $BSX - MarketBeat
Top Boston Scientific (BSX) Competitors 2026 - MarketBeat
Boston Scientific Corp (BSX) Reports Strong Success Rates From Catheter Study - Insider Monkey
Boston Scientific Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Boston Scientific stock hits 52-week low at 47.16 USD - Investing.com India
BTIG Remains Bullish On Boston Scientific (BSX); Check Out What It Says About The Stock - Insider Monkey
FY2026 EPS Estimate for Boston Scientific Lowered by Analyst - MarketBeat
Boston Scientific Corp Azioni (BSX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.18%
0.70%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):